nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylphenidate—Mood swings—Doxorubicin—uterine cancer	0.000641	0.000641	CcSEcCtD
Methylphenidate—Infection—Etoposide—uterine cancer	0.000637	0.000637	CcSEcCtD
Methylphenidate—Asthenia—Dactinomycin—uterine cancer	0.000636	0.000636	CcSEcCtD
Methylphenidate—Asthma—Epirubicin—uterine cancer	0.000632	0.000632	CcSEcCtD
Methylphenidate—Influenza—Epirubicin—uterine cancer	0.000632	0.000632	CcSEcCtD
Methylphenidate—Dehydration—Doxorubicin—uterine cancer	0.00063	0.00063	CcSEcCtD
Methylphenidate—Thrombocytopenia—Etoposide—uterine cancer	0.000628	0.000628	CcSEcCtD
Methylphenidate—Tachycardia—Etoposide—uterine cancer	0.000626	0.000626	CcSEcCtD
Methylphenidate—Liver function test abnormal—Doxorubicin—uterine cancer	0.000625	0.000625	CcSEcCtD
Methylphenidate—Skin disorder—Etoposide—uterine cancer	0.000623	0.000623	CcSEcCtD
Methylphenidate—Hyperhidrosis—Etoposide—uterine cancer	0.00062	0.00062	CcSEcCtD
Methylphenidate—Pancreatitis—Epirubicin—uterine cancer	0.00062	0.00062	CcSEcCtD
Methylphenidate—Abdominal pain upper—Doxorubicin—uterine cancer	0.000618	0.000618	CcSEcCtD
Methylphenidate—Angina pectoris—Epirubicin—uterine cancer	0.000616	0.000616	CcSEcCtD
Methylphenidate—Breast disorder—Doxorubicin—uterine cancer	0.000612	0.000612	CcSEcCtD
Methylphenidate—Anorexia—Etoposide—uterine cancer	0.000612	0.000612	CcSEcCtD
Methylphenidate—Bronchitis—Epirubicin—uterine cancer	0.000608	0.000608	CcSEcCtD
Methylphenidate—Diarrhoea—Dactinomycin—uterine cancer	0.000606	0.000606	CcSEcCtD
Methylphenidate—Nasopharyngitis—Doxorubicin—uterine cancer	0.000605	0.000605	CcSEcCtD
Methylphenidate—Pancytopenia—Epirubicin—uterine cancer	0.000601	0.000601	CcSEcCtD
Methylphenidate—Gastritis—Doxorubicin—uterine cancer	0.000599	0.000599	CcSEcCtD
Methylphenidate—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000597	0.000597	CcSEcCtD
Methylphenidate—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000588	0.000588	CcSEcCtD
Methylphenidate—Asthma—Doxorubicin—uterine cancer	0.000585	0.000585	CcSEcCtD
Methylphenidate—Influenza—Doxorubicin—uterine cancer	0.000585	0.000585	CcSEcCtD
Methylphenidate—Photosensitivity reaction—Epirubicin—uterine cancer	0.000577	0.000577	CcSEcCtD
Methylphenidate—Paraesthesia—Etoposide—uterine cancer	0.000576	0.000576	CcSEcCtD
Methylphenidate—Weight increased—Epirubicin—uterine cancer	0.000576	0.000576	CcSEcCtD
Methylphenidate—Pancreatitis—Doxorubicin—uterine cancer	0.000574	0.000574	CcSEcCtD
Methylphenidate—Weight decreased—Epirubicin—uterine cancer	0.000572	0.000572	CcSEcCtD
Methylphenidate—Dyspnoea—Etoposide—uterine cancer	0.000572	0.000572	CcSEcCtD
Methylphenidate—Somnolence—Etoposide—uterine cancer	0.00057	0.00057	CcSEcCtD
Methylphenidate—Angina pectoris—Doxorubicin—uterine cancer	0.00057	0.00057	CcSEcCtD
Methylphenidate—Pneumonia—Epirubicin—uterine cancer	0.000567	0.000567	CcSEcCtD
Methylphenidate—Infestation NOS—Epirubicin—uterine cancer	0.000564	0.000564	CcSEcCtD
Methylphenidate—Infestation—Epirubicin—uterine cancer	0.000564	0.000564	CcSEcCtD
Methylphenidate—Drowsiness—Epirubicin—uterine cancer	0.000564	0.000564	CcSEcCtD
Methylphenidate—Vomiting—Dactinomycin—uterine cancer	0.000564	0.000564	CcSEcCtD
Methylphenidate—Bronchitis—Doxorubicin—uterine cancer	0.000563	0.000563	CcSEcCtD
Methylphenidate—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000559	0.000559	CcSEcCtD
Methylphenidate—Rash—Dactinomycin—uterine cancer	0.000559	0.000559	CcSEcCtD
Methylphenidate—Decreased appetite—Etoposide—uterine cancer	0.000558	0.000558	CcSEcCtD
Methylphenidate—Pancytopenia—Doxorubicin—uterine cancer	0.000556	0.000556	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Etoposide—uterine cancer	0.000554	0.000554	CcSEcCtD
Methylphenidate—Fatigue—Etoposide—uterine cancer	0.000553	0.000553	CcSEcCtD
Methylphenidate—Constipation—Etoposide—uterine cancer	0.000549	0.000549	CcSEcCtD
Methylphenidate—Pain—Etoposide—uterine cancer	0.000549	0.000549	CcSEcCtD
Methylphenidate—Conjunctivitis—Epirubicin—uterine cancer	0.000548	0.000548	CcSEcCtD
Methylphenidate—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000544	0.000544	CcSEcCtD
Methylphenidate—Sweating—Epirubicin—uterine cancer	0.000541	0.000541	CcSEcCtD
Methylphenidate—Haematuria—Epirubicin—uterine cancer	0.000538	0.000538	CcSEcCtD
Methylphenidate—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000534	0.000534	CcSEcCtD
Methylphenidate—Hepatobiliary disease—Epirubicin—uterine cancer	0.000533	0.000533	CcSEcCtD
Methylphenidate—Weight increased—Doxorubicin—uterine cancer	0.000533	0.000533	CcSEcCtD
Methylphenidate—Epistaxis—Epirubicin—uterine cancer	0.000532	0.000532	CcSEcCtD
Methylphenidate—Weight decreased—Doxorubicin—uterine cancer	0.000529	0.000529	CcSEcCtD
Methylphenidate—Sinusitis—Epirubicin—uterine cancer	0.000529	0.000529	CcSEcCtD
Methylphenidate—Feeling abnormal—Etoposide—uterine cancer	0.000529	0.000529	CcSEcCtD
Methylphenidate—Nausea—Dactinomycin—uterine cancer	0.000527	0.000527	CcSEcCtD
Methylphenidate—Pneumonia—Doxorubicin—uterine cancer	0.000525	0.000525	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Etoposide—uterine cancer	0.000525	0.000525	CcSEcCtD
Methylphenidate—Infestation NOS—Doxorubicin—uterine cancer	0.000522	0.000522	CcSEcCtD
Methylphenidate—Drowsiness—Doxorubicin—uterine cancer	0.000522	0.000522	CcSEcCtD
Methylphenidate—Infestation—Doxorubicin—uterine cancer	0.000522	0.000522	CcSEcCtD
Methylphenidate—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000517	0.000517	CcSEcCtD
Methylphenidate—Bradycardia—Epirubicin—uterine cancer	0.000515	0.000515	CcSEcCtD
Methylphenidate—Urticaria—Etoposide—uterine cancer	0.00051	0.00051	CcSEcCtD
Methylphenidate—Haemoglobin—Epirubicin—uterine cancer	0.000509	0.000509	CcSEcCtD
Methylphenidate—Rhinitis—Epirubicin—uterine cancer	0.000507	0.000507	CcSEcCtD
Methylphenidate—Abdominal pain—Etoposide—uterine cancer	0.000507	0.000507	CcSEcCtD
Methylphenidate—Body temperature increased—Etoposide—uterine cancer	0.000507	0.000507	CcSEcCtD
Methylphenidate—Conjunctivitis—Doxorubicin—uterine cancer	0.000507	0.000507	CcSEcCtD
Methylphenidate—Haemorrhage—Epirubicin—uterine cancer	0.000506	0.000506	CcSEcCtD
Methylphenidate—Pharyngitis—Epirubicin—uterine cancer	0.000502	0.000502	CcSEcCtD
Methylphenidate—Sweating—Doxorubicin—uterine cancer	0.0005	0.0005	CcSEcCtD
Methylphenidate—Urinary tract disorder—Epirubicin—uterine cancer	0.0005	0.0005	CcSEcCtD
Methylphenidate—Haematuria—Doxorubicin—uterine cancer	0.000497	0.000497	CcSEcCtD
Methylphenidate—Connective tissue disorder—Epirubicin—uterine cancer	0.000497	0.000497	CcSEcCtD
Methylphenidate—Urethral disorder—Epirubicin—uterine cancer	0.000496	0.000496	CcSEcCtD
Methylphenidate—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000493	0.000493	CcSEcCtD
Methylphenidate—Epistaxis—Doxorubicin—uterine cancer	0.000492	0.000492	CcSEcCtD
Methylphenidate—Sinusitis—Doxorubicin—uterine cancer	0.000489	0.000489	CcSEcCtD
Methylphenidate—Visual impairment—Epirubicin—uterine cancer	0.000488	0.000488	CcSEcCtD
Methylphenidate—Erythema multiforme—Epirubicin—uterine cancer	0.000479	0.000479	CcSEcCtD
Methylphenidate—Bradycardia—Doxorubicin—uterine cancer	0.000477	0.000477	CcSEcCtD
Methylphenidate—Eye disorder—Epirubicin—uterine cancer	0.000473	0.000473	CcSEcCtD
Methylphenidate—Hypersensitivity—Etoposide—uterine cancer	0.000473	0.000473	CcSEcCtD
Methylphenidate—Haemoglobin—Doxorubicin—uterine cancer	0.000471	0.000471	CcSEcCtD
Methylphenidate—Cardiac disorder—Epirubicin—uterine cancer	0.00047	0.00047	CcSEcCtD
Methylphenidate—Flushing—Epirubicin—uterine cancer	0.00047	0.00047	CcSEcCtD
Methylphenidate—Rhinitis—Doxorubicin—uterine cancer	0.00047	0.00047	CcSEcCtD
Methylphenidate—Haemorrhage—Doxorubicin—uterine cancer	0.000468	0.000468	CcSEcCtD
Methylphenidate—Pharyngitis—Doxorubicin—uterine cancer	0.000465	0.000465	CcSEcCtD
Methylphenidate—Urinary tract disorder—Doxorubicin—uterine cancer	0.000463	0.000463	CcSEcCtD
Methylphenidate—Asthenia—Etoposide—uterine cancer	0.00046	0.00046	CcSEcCtD
Methylphenidate—Connective tissue disorder—Doxorubicin—uterine cancer	0.00046	0.00046	CcSEcCtD
Methylphenidate—Angiopathy—Epirubicin—uterine cancer	0.000459	0.000459	CcSEcCtD
Methylphenidate—Urethral disorder—Doxorubicin—uterine cancer	0.000459	0.000459	CcSEcCtD
Methylphenidate—Immune system disorder—Epirubicin—uterine cancer	0.000457	0.000457	CcSEcCtD
Methylphenidate—Mediastinal disorder—Epirubicin—uterine cancer	0.000456	0.000456	CcSEcCtD
Methylphenidate—Chills—Epirubicin—uterine cancer	0.000454	0.000454	CcSEcCtD
Methylphenidate—Pruritus—Etoposide—uterine cancer	0.000454	0.000454	CcSEcCtD
Methylphenidate—Arrhythmia—Epirubicin—uterine cancer	0.000452	0.000452	CcSEcCtD
Methylphenidate—Visual impairment—Doxorubicin—uterine cancer	0.000451	0.000451	CcSEcCtD
Methylphenidate—Alopecia—Epirubicin—uterine cancer	0.000447	0.000447	CcSEcCtD
Methylphenidate—Mental disorder—Epirubicin—uterine cancer	0.000443	0.000443	CcSEcCtD
Methylphenidate—Erythema multiforme—Doxorubicin—uterine cancer	0.000443	0.000443	CcSEcCtD
Methylphenidate—Malnutrition—Epirubicin—uterine cancer	0.000441	0.000441	CcSEcCtD
Methylphenidate—Erythema—Epirubicin—uterine cancer	0.000441	0.000441	CcSEcCtD
Methylphenidate—Diarrhoea—Etoposide—uterine cancer	0.000439	0.000439	CcSEcCtD
Methylphenidate—Eye disorder—Doxorubicin—uterine cancer	0.000438	0.000438	CcSEcCtD
Methylphenidate—Cardiac disorder—Doxorubicin—uterine cancer	0.000435	0.000435	CcSEcCtD
Methylphenidate—Flushing—Doxorubicin—uterine cancer	0.000435	0.000435	CcSEcCtD
Methylphenidate—Tension—Epirubicin—uterine cancer	0.000432	0.000432	CcSEcCtD
Methylphenidate—Nervousness—Epirubicin—uterine cancer	0.000428	0.000428	CcSEcCtD
Methylphenidate—Back pain—Epirubicin—uterine cancer	0.000426	0.000426	CcSEcCtD
Methylphenidate—Angiopathy—Doxorubicin—uterine cancer	0.000425	0.000425	CcSEcCtD
Methylphenidate—Dizziness—Etoposide—uterine cancer	0.000424	0.000424	CcSEcCtD
Methylphenidate—Muscle spasms—Epirubicin—uterine cancer	0.000424	0.000424	CcSEcCtD
Methylphenidate—Immune system disorder—Doxorubicin—uterine cancer	0.000423	0.000423	CcSEcCtD
Methylphenidate—Mediastinal disorder—Doxorubicin—uterine cancer	0.000422	0.000422	CcSEcCtD
Methylphenidate—Chills—Doxorubicin—uterine cancer	0.00042	0.00042	CcSEcCtD
Methylphenidate—Arrhythmia—Doxorubicin—uterine cancer	0.000418	0.000418	CcSEcCtD
Methylphenidate—Vision blurred—Epirubicin—uterine cancer	0.000415	0.000415	CcSEcCtD
Methylphenidate—Alopecia—Doxorubicin—uterine cancer	0.000414	0.000414	CcSEcCtD
Methylphenidate—Mental disorder—Doxorubicin—uterine cancer	0.00041	0.00041	CcSEcCtD
Methylphenidate—Ill-defined disorder—Epirubicin—uterine cancer	0.000409	0.000409	CcSEcCtD
Methylphenidate—Vomiting—Etoposide—uterine cancer	0.000408	0.000408	CcSEcCtD
Methylphenidate—Erythema—Doxorubicin—uterine cancer	0.000408	0.000408	CcSEcCtD
Methylphenidate—Malnutrition—Doxorubicin—uterine cancer	0.000408	0.000408	CcSEcCtD
Methylphenidate—Anaemia—Epirubicin—uterine cancer	0.000407	0.000407	CcSEcCtD
Methylphenidate—Agitation—Epirubicin—uterine cancer	0.000405	0.000405	CcSEcCtD
Methylphenidate—Rash—Etoposide—uterine cancer	0.000405	0.000405	CcSEcCtD
Methylphenidate—Dermatitis—Etoposide—uterine cancer	0.000404	0.000404	CcSEcCtD
Methylphenidate—Headache—Etoposide—uterine cancer	0.000402	0.000402	CcSEcCtD
Methylphenidate—Tension—Doxorubicin—uterine cancer	0.0004	0.0004	CcSEcCtD
Methylphenidate—Malaise—Epirubicin—uterine cancer	0.000397	0.000397	CcSEcCtD
Methylphenidate—Nervousness—Doxorubicin—uterine cancer	0.000396	0.000396	CcSEcCtD
Methylphenidate—Vertigo—Epirubicin—uterine cancer	0.000396	0.000396	CcSEcCtD
Methylphenidate—Syncope—Epirubicin—uterine cancer	0.000395	0.000395	CcSEcCtD
Methylphenidate—Leukopenia—Epirubicin—uterine cancer	0.000394	0.000394	CcSEcCtD
Methylphenidate—Back pain—Doxorubicin—uterine cancer	0.000394	0.000394	CcSEcCtD
Methylphenidate—Muscle spasms—Doxorubicin—uterine cancer	0.000392	0.000392	CcSEcCtD
Methylphenidate—Palpitations—Epirubicin—uterine cancer	0.000389	0.000389	CcSEcCtD
Methylphenidate—Loss of consciousness—Epirubicin—uterine cancer	0.000387	0.000387	CcSEcCtD
Methylphenidate—Cough—Epirubicin—uterine cancer	0.000385	0.000385	CcSEcCtD
Methylphenidate—Vision blurred—Doxorubicin—uterine cancer	0.000384	0.000384	CcSEcCtD
Methylphenidate—Convulsion—Epirubicin—uterine cancer	0.000382	0.000382	CcSEcCtD
Methylphenidate—Nausea—Etoposide—uterine cancer	0.000381	0.000381	CcSEcCtD
Methylphenidate—Hypertension—Epirubicin—uterine cancer	0.00038	0.00038	CcSEcCtD
Methylphenidate—Ill-defined disorder—Doxorubicin—uterine cancer	0.000378	0.000378	CcSEcCtD
Methylphenidate—Anaemia—Doxorubicin—uterine cancer	0.000377	0.000377	CcSEcCtD
Methylphenidate—Chest pain—Epirubicin—uterine cancer	0.000375	0.000375	CcSEcCtD
Methylphenidate—Arthralgia—Epirubicin—uterine cancer	0.000375	0.000375	CcSEcCtD
Methylphenidate—Myalgia—Epirubicin—uterine cancer	0.000375	0.000375	CcSEcCtD
Methylphenidate—Agitation—Doxorubicin—uterine cancer	0.000375	0.000375	CcSEcCtD
Methylphenidate—Anxiety—Epirubicin—uterine cancer	0.000374	0.000374	CcSEcCtD
Methylphenidate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000373	0.000373	CcSEcCtD
Methylphenidate—Discomfort—Epirubicin—uterine cancer	0.000371	0.000371	CcSEcCtD
Methylphenidate—Malaise—Doxorubicin—uterine cancer	0.000368	0.000368	CcSEcCtD
Methylphenidate—Dry mouth—Epirubicin—uterine cancer	0.000367	0.000367	CcSEcCtD
Methylphenidate—Vertigo—Doxorubicin—uterine cancer	0.000366	0.000366	CcSEcCtD
Methylphenidate—Syncope—Doxorubicin—uterine cancer	0.000366	0.000366	CcSEcCtD
Methylphenidate—Leukopenia—Doxorubicin—uterine cancer	0.000365	0.000365	CcSEcCtD
Methylphenidate—Confusional state—Epirubicin—uterine cancer	0.000363	0.000363	CcSEcCtD
Methylphenidate—Palpitations—Doxorubicin—uterine cancer	0.00036	0.00036	CcSEcCtD
Methylphenidate—Oedema—Epirubicin—uterine cancer	0.00036	0.00036	CcSEcCtD
Methylphenidate—Anaphylactic shock—Epirubicin—uterine cancer	0.00036	0.00036	CcSEcCtD
Methylphenidate—Loss of consciousness—Doxorubicin—uterine cancer	0.000358	0.000358	CcSEcCtD
Methylphenidate—Infection—Epirubicin—uterine cancer	0.000357	0.000357	CcSEcCtD
Methylphenidate—Cough—Doxorubicin—uterine cancer	0.000356	0.000356	CcSEcCtD
Methylphenidate—Shock—Epirubicin—uterine cancer	0.000354	0.000354	CcSEcCtD
Methylphenidate—Convulsion—Doxorubicin—uterine cancer	0.000353	0.000353	CcSEcCtD
Methylphenidate—Nervous system disorder—Epirubicin—uterine cancer	0.000353	0.000353	CcSEcCtD
Methylphenidate—Thrombocytopenia—Epirubicin—uterine cancer	0.000352	0.000352	CcSEcCtD
Methylphenidate—Hypertension—Doxorubicin—uterine cancer	0.000352	0.000352	CcSEcCtD
Methylphenidate—Tachycardia—Epirubicin—uterine cancer	0.000351	0.000351	CcSEcCtD
Methylphenidate—Skin disorder—Epirubicin—uterine cancer	0.000349	0.000349	CcSEcCtD
Methylphenidate—Hyperhidrosis—Epirubicin—uterine cancer	0.000348	0.000348	CcSEcCtD
Methylphenidate—Chest pain—Doxorubicin—uterine cancer	0.000347	0.000347	CcSEcCtD
Methylphenidate—Arthralgia—Doxorubicin—uterine cancer	0.000347	0.000347	CcSEcCtD
Methylphenidate—Myalgia—Doxorubicin—uterine cancer	0.000347	0.000347	CcSEcCtD
Methylphenidate—Anxiety—Doxorubicin—uterine cancer	0.000346	0.000346	CcSEcCtD
Methylphenidate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000345	0.000345	CcSEcCtD
Methylphenidate—Discomfort—Doxorubicin—uterine cancer	0.000343	0.000343	CcSEcCtD
Methylphenidate—Anorexia—Epirubicin—uterine cancer	0.000343	0.000343	CcSEcCtD
Methylphenidate—Dry mouth—Doxorubicin—uterine cancer	0.000339	0.000339	CcSEcCtD
Methylphenidate—Confusional state—Doxorubicin—uterine cancer	0.000336	0.000336	CcSEcCtD
Methylphenidate—Anaphylactic shock—Doxorubicin—uterine cancer	0.000333	0.000333	CcSEcCtD
Methylphenidate—Oedema—Doxorubicin—uterine cancer	0.000333	0.000333	CcSEcCtD
Methylphenidate—Infection—Doxorubicin—uterine cancer	0.000331	0.000331	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000328	0.000328	CcSEcCtD
Methylphenidate—Shock—Doxorubicin—uterine cancer	0.000327	0.000327	CcSEcCtD
Methylphenidate—Nervous system disorder—Doxorubicin—uterine cancer	0.000326	0.000326	CcSEcCtD
Methylphenidate—Thrombocytopenia—Doxorubicin—uterine cancer	0.000326	0.000326	CcSEcCtD
Methylphenidate—Insomnia—Epirubicin—uterine cancer	0.000325	0.000325	CcSEcCtD
Methylphenidate—Tachycardia—Doxorubicin—uterine cancer	0.000325	0.000325	CcSEcCtD
Methylphenidate—Skin disorder—Doxorubicin—uterine cancer	0.000323	0.000323	CcSEcCtD
Methylphenidate—Paraesthesia—Epirubicin—uterine cancer	0.000323	0.000323	CcSEcCtD
Methylphenidate—Hyperhidrosis—Doxorubicin—uterine cancer	0.000322	0.000322	CcSEcCtD
Methylphenidate—Dyspnoea—Epirubicin—uterine cancer	0.000321	0.000321	CcSEcCtD
Methylphenidate—Somnolence—Epirubicin—uterine cancer	0.00032	0.00032	CcSEcCtD
Methylphenidate—Anorexia—Doxorubicin—uterine cancer	0.000317	0.000317	CcSEcCtD
Methylphenidate—Dyspepsia—Epirubicin—uterine cancer	0.000317	0.000317	CcSEcCtD
Methylphenidate—Decreased appetite—Epirubicin—uterine cancer	0.000313	0.000313	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Epirubicin—uterine cancer	0.00031	0.00031	CcSEcCtD
Methylphenidate—Fatigue—Epirubicin—uterine cancer	0.00031	0.00031	CcSEcCtD
Methylphenidate—Pain—Epirubicin—uterine cancer	0.000308	0.000308	CcSEcCtD
Methylphenidate—Constipation—Epirubicin—uterine cancer	0.000308	0.000308	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000303	0.000303	CcSEcCtD
Methylphenidate—Insomnia—Doxorubicin—uterine cancer	0.000301	0.000301	CcSEcCtD
Methylphenidate—Paraesthesia—Doxorubicin—uterine cancer	0.000299	0.000299	CcSEcCtD
Methylphenidate—Dyspnoea—Doxorubicin—uterine cancer	0.000297	0.000297	CcSEcCtD
Methylphenidate—Feeling abnormal—Epirubicin—uterine cancer	0.000296	0.000296	CcSEcCtD
Methylphenidate—Somnolence—Doxorubicin—uterine cancer	0.000296	0.000296	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Epirubicin—uterine cancer	0.000294	0.000294	CcSEcCtD
Methylphenidate—Dyspepsia—Doxorubicin—uterine cancer	0.000293	0.000293	CcSEcCtD
Methylphenidate—Decreased appetite—Doxorubicin—uterine cancer	0.000289	0.000289	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000287	0.000287	CcSEcCtD
Methylphenidate—Fatigue—Doxorubicin—uterine cancer	0.000287	0.000287	CcSEcCtD
Methylphenidate—Urticaria—Epirubicin—uterine cancer	0.000286	0.000286	CcSEcCtD
Methylphenidate—Pain—Doxorubicin—uterine cancer	0.000285	0.000285	CcSEcCtD
Methylphenidate—Constipation—Doxorubicin—uterine cancer	0.000285	0.000285	CcSEcCtD
Methylphenidate—Abdominal pain—Epirubicin—uterine cancer	0.000284	0.000284	CcSEcCtD
Methylphenidate—Body temperature increased—Epirubicin—uterine cancer	0.000284	0.000284	CcSEcCtD
Methylphenidate—Feeling abnormal—Doxorubicin—uterine cancer	0.000274	0.000274	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000272	0.000272	CcSEcCtD
Methylphenidate—Hypersensitivity—Epirubicin—uterine cancer	0.000265	0.000265	CcSEcCtD
Methylphenidate—Urticaria—Doxorubicin—uterine cancer	0.000264	0.000264	CcSEcCtD
Methylphenidate—Body temperature increased—Doxorubicin—uterine cancer	0.000263	0.000263	CcSEcCtD
Methylphenidate—Abdominal pain—Doxorubicin—uterine cancer	0.000263	0.000263	CcSEcCtD
Methylphenidate—Asthenia—Epirubicin—uterine cancer	0.000258	0.000258	CcSEcCtD
Methylphenidate—Pruritus—Epirubicin—uterine cancer	0.000254	0.000254	CcSEcCtD
Methylphenidate—Diarrhoea—Epirubicin—uterine cancer	0.000246	0.000246	CcSEcCtD
Methylphenidate—Hypersensitivity—Doxorubicin—uterine cancer	0.000245	0.000245	CcSEcCtD
Methylphenidate—Asthenia—Doxorubicin—uterine cancer	0.000239	0.000239	CcSEcCtD
Methylphenidate—Dizziness—Epirubicin—uterine cancer	0.000238	0.000238	CcSEcCtD
Methylphenidate—Pruritus—Doxorubicin—uterine cancer	0.000235	0.000235	CcSEcCtD
Methylphenidate—Vomiting—Epirubicin—uterine cancer	0.000229	0.000229	CcSEcCtD
Methylphenidate—Diarrhoea—Doxorubicin—uterine cancer	0.000228	0.000228	CcSEcCtD
Methylphenidate—Rash—Epirubicin—uterine cancer	0.000227	0.000227	CcSEcCtD
Methylphenidate—Dermatitis—Epirubicin—uterine cancer	0.000227	0.000227	CcSEcCtD
Methylphenidate—Headache—Epirubicin—uterine cancer	0.000225	0.000225	CcSEcCtD
Methylphenidate—Dizziness—Doxorubicin—uterine cancer	0.00022	0.00022	CcSEcCtD
Methylphenidate—Nausea—Epirubicin—uterine cancer	0.000214	0.000214	CcSEcCtD
Methylphenidate—Vomiting—Doxorubicin—uterine cancer	0.000212	0.000212	CcSEcCtD
Methylphenidate—Rash—Doxorubicin—uterine cancer	0.00021	0.00021	CcSEcCtD
Methylphenidate—Dermatitis—Doxorubicin—uterine cancer	0.00021	0.00021	CcSEcCtD
Methylphenidate—Headache—Doxorubicin—uterine cancer	0.000208	0.000208	CcSEcCtD
Methylphenidate—Nausea—Doxorubicin—uterine cancer	0.000198	0.000198	CcSEcCtD
